Michael Halstead Sells 22,869 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) President Michael Halstead sold 22,869 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $89.12, for a total value of $2,038,085.28. The sale was disclosed in a legal filing with the SEC, which is available at […]
More Stories
Croda International (OTCMKTS:COIHD) Sets New 1-Year Low – Time to Sell?
Croda International Plc (OTCMKTS:COIHD – Get Free Report)’s share price reached a new 52-week low on Tuesday . The stock...
iShares ESG Aware MSCI EAFE ETF (NASDAQ:ESGD) Short Interest Update
iShares ESG Aware MSCI EAFE ETF (NASDAQ:ESGD – Get Free Report) was the recipient of a significant increase in short...
Earlyworks Co., Ltd (NASDAQ:ELWS) Short Interest Update
Earlyworks Co., Ltd (NASDAQ:ELWS – Get Free Report) saw a significant increase in short interest during the month of October....
SSP Group (OTCMKTS:SSPPF) Sets New 12-Month High – What’s Next?
Shares of SSP Group plc (OTCMKTS:SSPPF – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday...
Hays (OTCMKTS:HAYPY) Hits New 12-Month Low – Here’s What Happened
Hays plc (OTCMKTS:HAYPY – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday ....
Rocket Internet (FRA:RKET) Shares Up ∞ – Here’s Why
Rocket Internet SE (FRA:RKET – Get Free Report) traded up ∞ on Tuesday . The company traded as high as...